4
Changes in Ownership
Dogwood Therapeutics, Inc. Filed Acc 0001104659-20-138202
Options or other derivatives
- Chief Executive Officer acquired 414,125 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Duncan Gregory Scott · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +414,125 | 414,125 | D |
Loading xslF345X03/tm2039099-4_4.xml…